| Advances in Neuropsychiatric Treatment |
| |
| FEATURED SPEAKER |
David Bredt, M.D. Ph.D.
Global Head, Neuroscience Discovery
Johnson & Johnson |
| |
| DISTINGUISHED SPEAKERS |
| |
Mark Demitrack, M.D.
Vice President and Chief Medical Officer
Neuronetics
|
| |
Gül Dölen, M.D. Ph.D.
Post-Doctoral Fellow, Psychiatry
Stanford University
|
| |
Fiona Gaughran, M.D.
Associate Clinical Director, Complex Care Pathway
Psychosis Clinical Academic Group
|
| |
Luis Hernandez-Garcia, Ph.D.
Associate Professor, Biomedical Engineering
University of Michigan
|
| |
Gerard Marek, M.D. Ph.D.
Project Director, Neuroscience Development
Abbott
|
| |
Dieter J. Meyeroff, Ph.D.
Professor, Radiology
UC San Francisco
|
| |
Cort A. Pedersen, M.D.
Professor, Psychiatry
University of North Carolina School of Medicine
|
| |
Adam Savitz, Ph.D.
Assistant Professor, Psychiatry
Weill Cornell Medical College
|
| |
Phil Skolnick, Ph.D.
Director, Pharmacotherapies and Medical Consequences of Drug Abuse
National Inistitute on Drug Abuse, NIH
|
| |
Gabriel Vargas, M.D. Ph.D.
Head, CNS Clinical Biomarkers
Amgen
|
| |
Min Zhang, Ph.D.
Neuroscience Research
Abbott
|
| |
| Please check back for updates! |
| |
| Top of the Page |
|
| 5th Neurodegenerative Conditions Research and Development |
| |
| DISTINGUISHED SPEAKERS |
| |
Eric Parker – Featured Speaker
Senior Director and Site Lead, Neuroscience
Merck |
| |
Susan Abushakra, M.D.
Vice President and Program Lead, Alzheimer’s Disease
Elan Pharmaceuticals |
| |
Kelly R. Bales, Ph.D.
Research Fellow, Neuroscience Research Unit
Pfizer |
| |
Manuela Basso, Ph.D.
Junior Faculty Member, Rajiv Ratan Lab
Burke
|
| |
Marcelle Bergeron, Ph.D.
Director, Neuropharmacology
Elan Pharmaceuticals
|
| |
Jonathan Brotchie, Ph.D.
Senior Scientist, Toronto Western Research Institute
Toronto Western Hospital
|
| |
Roger Bullock, Ph.D.
Director
Kingshill Research Centre
|
| |
Steven C. Cramer, M.D.
Professor, Neurology, Anatomy and Neurobiology
University of California
|
| |
Ronald B. DeMattos, Ph.D.
Senior Research Advisor, Neuroscience Division
Lilly Research Laboratories
|
| |
Santosh R. D'Mello, Ph.D.
Professor, Molecular and Cell Biology
University of Texas
|
| |
Thomas M. Engber, Ph.D.
Director, Discovery Neurobiology
Biogen Idec
|
| |
Luke Esposito, Ph.D.
Director, Neuroscience Research
Proteotech
|
| |
Kimberley S. Gannon, Ph.D.
VP, Preclinical Research and Development
NeuroPhage Pharmaceuticals |
| |
Klaudyne Hong, Ph.D. - Moderator
Team Leader and Principal Scientist, Stroke Cell Therapy
Johnson & Johnson |
| |
Jacqueline Kirchner, Ph.D.
Scientific Director, Inflammation
Amgen
|
| |
Orly Lazarov, Ph.D.
Associate Professor, Anatomy and Cell Biology
University of Illinois |
| |
Frank M. Longo, M.D. Ph.D.
George E. and Lucy Becker Professor; Chairman, Neurology and Neurological Sciences
Stanford School of Medicine
|
| |
Babu Narayanan
Senior Scientist, Computing & Decision Sciences Lab
GE Global Research |
| |
François Nicolas
Biosignature Technology Leader
GE Healthcare |
| |
Salvatore Oddo, Ph.D.
Assistant Professor, Physiology
University of Texas Health Science Center |
| |
Giulio M. Pasinetti, M.D. Ph.D.
Professor, Psychiatry, Neuroscience, Geriatrics and Adult Development
Mount Sinai School of Medicine |
| |
Domenico Pratico, M.D.
Associate Professor, Pharmacology, Microbiology and Immunology
Temple University |
| |
Lorenzo M. Refolo, Ph.D.
Division of Neuroscience, Dementias of Aging Branch
National Institute on Aging |
| |
Jukka Sallinen, M.D. Ph.D.
Head, CNS Research
Orion Pharma |
| |
Kiminobu Sugaya
Professor, Burnett School of Biomedical Sciences
University of Central Florida |
| |
Olof Zachrisson
Section Head, Vivo Pharmacology
NeuroNova |
| |
| Please check back for updates! |
| |
| Top of the Page |
|
| |
| 4th CNS Partnering and Deal-making |
| |
| DISTINGUISHED SPEAKERS and ADVISORY BOARD MEMBERS |
| |
| |
Joseph Araujo
Vice President and CFO
CanCog Technologies
Jens Bitsch-Norhave
Director, Business Licensing, PGBD
Johnson&Johnson c/o Janssen Pharmaceutica
Christine de los Reyes
Founder and Managing Director
BiotechPartnering Solutions, LLC
Lubor Gaal
Executive Director, Neuroscience, Strategic Transactions Group
Bristol-Myers Squibb
Marcie Glicksman
Co-Director Laboratory for Drug Discovery
Brigham and Women's Hospital
Timothy Herpin
Director, Strategic Transactions Group
Bristol-Myers Squibb
Manuel O. Lopez-Figueroa
Vice President
Bay City Capital; Pritzker Neuropsychiatric Disorders Research Consortium
Deborah Rathjen
CEO & Managing Director
Bionomics
Luca Santarelli
Global Head of CNS
Roche
Bavani Shankar
Vice President, Corporate Development
PsychoGenics Inc.
Michael M. Shih
Senior Director, Business Development
Eisai Inc.
Shafique Virani
Global Head CNS Business Development & Licensing
F. Hoffmann-La Roche LTD
Yue Wang
Head, Electrophysiology Facility
NIA/NIH
|